Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

Background: This review provides a comprehensive summary of the production of 177 Lu to
meet expected future research and clinical demands. Availability of options represents the …

Interest in the use of radionuclides for treatment of various diseases has a long history and
parallels the isolation of radium by Marie and Pierre Curie in the early part of the 20th …

Peptide receptor radionuclide therapy (PRRT) is a site-directed targeted therapeutic strategy
that specifically uses radiolabeled peptides as biological targeting vectors designed to …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

Porous carbon materials stemming from covalent organic frameworks (COFs) have emerged
as pivotal candidates in various fields. However, no COF or relevant derivative has stepped …

Lutetium-177 [T½= 6.76 d; Eβ (max)= 0.497 MeV; maximum tissue range~ 2.5 mm; 208 keV
γ-ray] is one of the most important theranostic radioisotope used for the management of …

Nuclear medicine continues to represent one of the important modalities for cancer
management. While diagnostic nuclear medicine for cancer management is fairly well …

Peptide receptor radionuclide therapy (PRRT), over the years, has evolved as an important
modality in the therapeutic armamentarium of advanced, metastatic or inoperable …

Abstract Scandium-44/47 is one of the emerging theranostic pair of radiometals which can
revolutionize nuclear medicine procedures in both diagnosis as well as targeted …